Effect of temperature on the radioiodination of human growth hormone.
Studies have been undertaken to assess the effect of altering the temperature at which human growth hormone is radioiodinated on the incorporation of 125 Iodine and the immunoreactivity and stability of the labelled hormone. Employing highly purified monomeric hormone it proved possible, by the iodogen procedure, to prepare a labelled product of high specific activity irrespective of temperature. However, in radioiodinations performed at ambient temperature (20 to 25 degrees) significant amounts of the labelled hormone were in an aggregated form which was less immunoreactive than the 125 Iodine-labelled monomeric hormone. Such aggregation was largely prevented by radioiodinating at low temperature (0 to 4 degrees) and even the large monomeric peak was more immunoreactive (about 95% bound in antibody excess) than the monomeric peak from iodinations performed at room temperature (maximum binding 87%, or less).
D001666:Binding Sites, Antibody; D003080:Cold Temperature; D013006:Growth Hormone / Q000097:blood* / Q000302:isolation & purification; D006358:Hot Temperature; D006801:Humans; D007457:Iodine Radioisotopes / Q000378:metabolism*; D011863:Radioimmunoassay / Q000379:methods; D013696:Temperature
D007457:Iodine Radioisotopes; D013006:Growth Hormone